Visiting from the US? Discover Helixafe, our Cancer Driver Interception program →
What we do
About Bioscience
Brochures
Science & innovation News & media Shop NowTalk to an expert
Italianoالعربية中文

Prenatal & neonatal genomics

Carrier Screening

Identifying hidden genetic risks before pregnancy with Expanded Carrier Test

MYCARRIER is an expanded carrier screening test that analyzes the DNA of one or both prospective parents to identify genetic variants associated with certain diseases and to assess the risk that the unborn child may develop one of them or be a healthy carrier.

Information brochure

Why choose MYCARRIER?

MYCARRIER is an expanded carrier screening test that, through DNA sequencing and sophisticated bioinformatics algorithms, can detect mutations in more than 1,200 genes associated with over 1,200 diseases. The sensitivity and specificity of the test are above 99.9%.

The process of identifying known variants through high-throughput Target NGS sequencing is validated with gold-standard methods, such as Sanger sequencing and other molecular biology techniques (MLPA, qPCR and gap-PCR). The added value of the analysis lies in the clinical interpretation of the result, which makes the information obtained clear and usable.

Screening levels

MYCARRIER is offered at five levels of investigation.

Click on each box to view the complete list of the diseases investigated and the genes analyzed by the MYCARRIER test.

MYCARRIER Base
MYCARRIER Plus
MYCARRIER Top

The search for Fragile X is always included in the MYCARRIER tests.

MYCARRIER Emo
MYCARRIER Talass

Advantages of the test

  • A BLOOD DRAW IS ENOUGH
  • 1 ANALYSIS OPTION FOR A SINGLE DISEASE (Fragile X)
  • 3 EXPANDED ANALYSIS OPTIONS (up to 1,200 diseases)
  • RESULT IN ABOUT 21* WORKING DAYS
  • GENETIC COUNSELING** CAN BE REQUESTED

* 30 for the Top version.
** Requesting genetic counseling involves additional costs.

Who the test is for

Carrier screening can provide important information for couples who:

  • are planning a pregnancy or already have one in progress.
  • are at higher risk for a specific genetic disease.
  • are planning heterologous fertilization (donor conception).
  • wish to assess the risk of having a child affected by a genetic disease.

Request the test

To request MYCARRIER or to get more information about the test, fill in the form below or call us (from Italy, toll-free: 800 690914). Our biologists will answer your requests with no obligation on your part.

Translation of scientific content reviewed by the Bioscience Institute Scientific Board. · Last updated

The information on this page is for general education and does not replace a consultation with a physician.

This page in other languages: Italiano العربية 中文

Prenatal & neonatal genomics

Request information

Tell us your situation and a specialist from this area will get back to you, in your country and your language.

Prenatal screening estimates risk; a positive result is confirmed with a diagnostic test prescribed by your gynaecologist.

Prenatal & neonatal genomics

Non-invasive prenatal screening from week 10, carrier screening for parents and expanded screening for newborns.

Non-invasive prenatal screening from week 10, validated on 112,669 pregnancies, with carrier screening for parents and expanded screening for newborns in the first days of life.

Connect with us on social

Helixafe · US